Narayana Hrudayalaya Ltd
NSE: NH BSE: 539551
₹1766.60
(-0.21%)
Tue, 05 May 2026, 05:16 pm
Market Cap361.46B
PE Ratio46.13
Dividend0.25
24.5KNarayana Hrudayalaya Analysis
dividend
- Dividends paid are well covered by earnings (5.9x coverage).
- Dividends after 3 years are expected to be well covered by earnings (5.9x coverage).
- Narayana Hrudayalaya only just started paying a dividend, it is too early to tell if payments are increasing.
- It is too early to tell whether Narayana Hrudayalaya has stable dividend payments.
- Narayana Hrudayalaya's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
- Narayana Hrudayalaya's dividend is below the markets top 25% of dividend payers in India (3.08%).
future
- Narayana Hrudayalaya's earnings are expected to grow significantly at over 20% yearly.
- Narayana Hrudayalaya's earnings growth is expected to exceed the India market average.
- Narayana Hrudayalaya's earnings growth is expected to exceed the low risk savings rate of 7.2%.
- Narayana Hrudayalaya's earnings are expected to exceed the low risk growth rate next year.
- Narayana Hrudayalaya's net income is expected to increase by more than 50% in 2 years time.
- Performance (ROE) is expected to be above the current IN Healthcare industry average.
- An improvement in Narayana Hrudayalaya's performance (ROE) is expected over the next 3 years.
- Narayana Hrudayalaya's revenue growth is expected to exceed the India market average.
- Cash flow for Narayana Hrudayalaya is expected to increase but not above the 50% threshold in 2 years time.
- Narayana Hrudayalaya is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
- Narayana Hrudayalaya's revenue is expected to increase but not above the 50% threshold in 2 years time.
- Narayana Hrudayalaya's revenue is expected to grow by 10% yearly, however this is not considered high growth (20% yearly).
health
- Narayana Hrudayalaya is profitable, therefore cash runway is not a concern.
- Narayana Hrudayalaya is profitable, therefore cash runway is not a concern.
- Debt is well covered by operating cash flow (70.4%, greater than 20% of total debt).
- Interest payments on debt are well covered by earnings (EBIT is 3.1x coverage).
- Narayana Hrudayalaya's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
- Debt is not covered by short term assets, assets are 0.9x debt.
- Narayana Hrudayalaya's long term commitments exceed its cash and other short term assets.
- The level of debt compared to net worth has increased over the past 5 years (47% vs 55.4% today).
- Narayana Hrudayalaya's level of debt (55.4%) compared to net worth is high (greater than 40%).
- High level of physical assets or inventory.
management
- The tenure for the Narayana Hrudayalaya board of directors is about average.
- Emmanuel's remuneration is lower than average for companies of similar size in India.
- The tenure for the Narayana Hrudayalaya management team is about average.
past
- Narayana Hrudayalaya's 1-year earnings growth exceeds its 5-year average (99.7% vs 32.2%)
- Narayana Hrudayalaya has delivered over 20% year on year earnings growth in the past 5 years.
- Narayana Hrudayalaya's earnings growth has exceeded the IN Healthcare industry average in the past year (99.7% vs 14.4%).
- Narayana Hrudayalaya used its assets less efficiently than the IN Healthcare industry average last year based on Return on Assets.
- Narayana Hrudayalaya's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
- Narayana Hrudayalaya has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
value
- 539551 outperformed the Healthcare industry which returned 9.1% over the past year.
- 539551 outperformed the Market in India which returned -14.5% over the past year.
- BSE:539551 is up 5.7% along with the Healthcare industry (5.4%) over the past month.
- Narayana Hrudayalaya's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).
- Narayana Hrudayalaya's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).
- Narayana Hrudayalaya is overvalued based on assets compared to the IN Healthcare industry average.
- Narayana Hrudayalaya is poor value based on expected growth next year.
- Narayana Hrudayalaya is overvalued based on earnings compared to the IN Healthcare industry average.
- Narayana Hrudayalaya is overvalued based on earnings compared to the India market.
- BSE:539551 is up 5.7% underperforming the market in India which returned 8% over the past month.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800